Cutia Therapeutics says NMPA accepted biologics license application
Cutia Therapeutics (HKEX:2487) said China’s NMPA accepted its biologics license application for CU-20101.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.